NCT07212452View on ClinicalTrials.gov

Tranexamic Acid : Nebulization vs IV Route for Hemoptysis

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions
HemoptysisNEBULIZATIONTranexamic Acid
Interventions
DRUG

Tranexamic Acid (TXA)

In this study we are comparing the effect of tranexamic acid on hemoptysis when given through IV route and nebulization

Trial Locations (1)

54000

RECRUITING

Services Hospital Lahore, Lahore

All Listed Sponsors
lead

University of Health Sciences Lahore

OTHER

NCT07212452 - Tranexamic Acid : Nebulization vs IV Route for Hemoptysis | Biotech Hunter | Biotech Hunter